1. Home
  2. Analysis
  3. Gemtesa
  4. Oedema-peripheral

Gemtesa and Oedema peripheral - a phase IV clinical study of FDA data

Summary:

Oedema peripheral is reported as a side effect among people who take Gemtesa (vibegron), especially for people who are female, 60+ old, also take Omeprazole, and have Hypertonic bladder.

The phase IV clinical study analyzes which people have Oedema peripheral when taking Gemtesa. It is created by eHealthMe based on reports of 2,622 people who have side effects when taking Gemtesa from the FDA, and is updated regularly.

What is Gemtesa?

Gemtesa has active ingredients of vibegron. eHealthMe is studying from 2,648 Gemtesa users. Check the latest studies of Gemtesa.

What is Oedema peripheral?

Oedema peripheral (superficial swelling) is found to be associated with 2,772 drugs and 3,465 conditions by eHealthMe. Check the latest studies of Oedema peripheral.

On Jul, 13, 2026

2,622 people reported to have side effects when taking Gemtesa.
Among them, 13 people (0.5%) have Oedema peripheral.

Could Gemtesa cause Oedema peripheral?

Among these 13 people:

What is the gender of people who have Oedema peripheral when taking Gemtesa? *

  • female: 83.33 %
  • male: 16.67 %

What is the age of people who have Oedema peripheral when taking Gemtesa? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 33.33 %
  • 60+: 66.67 %

What are other drugs people take besides Gemtesa? *

  1. Gabapentin: 2 people, 15.38%
  2. Omeprazole: 2 people, 15.38%
  3. Eliquis: 1 person, 7.69%
  4. Emsam: 1 person, 7.69%
  5. Epinephrine: 1 person, 7.69%
  6. Flovent Hfa: 1 person, 7.69%
  7. Fluticasone Propionate: 1 person, 7.69%
  8. Folic Acid: 1 person, 7.69%
  9. Fosamax: 1 person, 7.69%
  10. Furosemide: 1 person, 7.69%

What are other side effects people have besides Oedema peripheral? *

  1. Pain: 3 people, 23.08%
  2. Fall: 2 people, 15.38%
  3. Fatigue (feeling of tiredness): 2 people, 15.38%
  4. Back Pain: 2 people, 15.38%
  5. Loss Of Consciousness: 2 people, 15.38%
  6. Peripheral Swelling: 2 people, 15.38%
  7. Incontinence (lack of moderation or self-control): 1 person, 7.69%
  8. Ill-Defined Disorder: 1 person, 7.69%
  9. Hypervolaemia (abnormally increased volume of blood): 1 person, 7.69%
  10. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 7.69%

What are the existing conditions these people have? *

  1. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 15.38%
  2. Inflammation: 1 person, 7.69%
  3. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 7.69%
  4. Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Gemtesa and have Oedema peripheral?

- Check whether Oedema peripheral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemtesa:

Oedema peripheral treatments and more:

How severe was Oedema peripheral and when was it recovered:

Expand to all the drugs that have ingredients of vibegron:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gemtesa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oedema peripheral:

Browse all the conditions that are associated with Oedema peripheral:

How the study uses the data?

The study uses data from the FDA. It is based on vibegron (the active ingredients of Gemtesa) and Gemtesa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.